Stryker Corporation (SYK) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Devices
Stryker Corporation (SYK) Profile & Business Summary
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Key Information
| Ticker | SYK |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.stryker.com |
Market Trend Overview for SYK
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-14 (ET)
As of 2026-07-14, SYK is showing signs of slowing down. Over the longer term, the trend remains bearish.
SYK last closed at 311.07. The price is about 0.4 ATR below its recent average price (314.62), and the market is currently in a trend that may be losing strength. Price at 311.07 is near minor support around 300.21. Momentum may slow, while minor resistance sits near 322.87. View Support & Resistance from Options
Short-term strength is developing against a weaker long-term trend, which increases the risk of downside reversals.
Trend score: 45 out of 100. Overall alignment is unclear. The market is currently in a late-stage trend that may be losing strength. The longer-term trend is still negative, but short-term signals are not yet confirming it.
A key downside risk boundary is near 291.26. If price falls below this area, the current structure would likely weaken further.
On 2026-07-14, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-06-10] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
There was no clear sign of meaningful positions being carried into the overnight session.
The model sees a bearish edge, but still treats it as a selective downside setup rather than an aggressive downside call.
Up probability is only 41.8%, with predictability at 51% and agreement at 82%. Reversal risk is 23%. That suggests downside pressure is present, while the setup still remains selective rather than extreme. At the same time, price is still close to a gamma transition zone.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is trading 3.1% below the recent estimated cost basis of 320.92, so the recent structure is still leaning under pressure. Price is below the main cost band (326.32 to 333.60), and roughly 83% of recent positioning remains under water. That means rebounds can still run into supply from trapped holders. The higher up selling area sits around 324.95 to 334.06, so rebounds may begin to slow as price pushes into that zone. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, this setup remains tougher until price can reclaim the lower edge of the main cost band near 326.32.